Tacere Therapeutics
, a San Jose biotech start-up has raised seed financing to develop treatments for serious infectious diseases.

The financing came from from Hokkaido Venture Capital.

The company is developing a drug called “TT-033i,” for the treatment of Hepatitis C (HCV). See details here.